Who invested in Allorion Therapeutics?
Allorion Therapeutics's investors include Qiming Venture Partners and IDG Capital.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2023, from 1 source
Allorion Therapeutics's investors include Qiming Venture Partners and IDG Capital.
Allorion Therapeutics has raised $50M across 1 round since 2023.
Allorion Therapeutics's most recent round was a Series B of $50M in Mar 2023.
Its most recent round, $50M in Mar 2023, is also its largest on record.
Allorion Therapeutics's first round on record, in Mar 2023, was backed by Qiming Venture Partners and IDG Capital.
Allorion Therapeutics's latest named round is a Series B, in Mar 2023.
Allorion Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.